Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy & Safety of Bevacizumab as Neoadjuvant Treatment in Patients With Locally Advanced Inflammatory Breast Cancer, a Pilot Study.

NCT01880385 is registered in ClinicalTrials.gov with Association Tunisienne de lutte Contre le Cancer as lead sponsor.

NCT NCT01880385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01880385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy & Safety of Bevacizumab as Neoadjuvant Treatment in Patients With Locally Advanced Inflammatory Breast Cancer, a Pilot Study.
Lead sponsor
Association Tunisienne de lutte Contre le Cancer
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2011
Completion date
April 30, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory breast cancer